Medplus Health Services shares added 3 % in early commerce on February 26 even after the corporate’s subsidiary acquired a suspension order from Drugs and Control Authorities of Mahabubnagar, Telangana.

At 9:37am Medplus Health Services was quoting Rs 710.10, up Rs 20.90, or 3.03 %, on the BSE.

The assistant director of Drugs Control Administration, Mahabubnagar, Telangana, has issued short-term suspension of drug licence for 9 days to a retailer at in Wanaparthy, Mahabubnagar.

The firm acquired the order on February 23 and estimated a possible income lack of Rs 1.63 lakh.

Catch all market action in our live blog

Earlier this month, the Thane Food and Drug Administration had suspended the drug licence for the shop in Khopat Thane for 15 days for violation of assorted circumstances.

In January, the corporate acquired orders from the assistant director and drug gross sales licensing authority of the Drug Control Administration, Mahabubnagar TS, for suspension of licence for six days for retailer at Shankarayapally Jadcherla, and one other for the suspension of licence for seven days for a retailer at Hayath Nagar.

The firm’s web revenue rose 2.4 % at Rs 13.73 crore within the quarter ended December 2023.

The share touched a 52-week excessive of Rs 977.45 and a 52-week low of Rs 597.95 on 31 July, 2023 and 14 February, 2024, respectively. Currently, the inventory is buying and selling 27.35 % beneath its 52-week excessive and 18.76 % above its 52-week low.

Disclaimer: The views and funding suggestions expressed by funding consultants on Moneycontrol.com are their very own and never these of the web site or its administration. Moneycontrol.com advises customers to test with licensed consultants earlier than taking any funding selections.